InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Lawyers react to Myriad decision

Karen Bolipata and Eileen McDermott, New York


Friday’s much anticipated decision in Association for Molecular Pathology v the USPTO and Myriad Genetics came as a relief to those who feared an outcome that would undo “essential building blocks” of the biotech industry, said patent lawyers

“[A decision in favour of AMP] could have had devastating consequences in terms of lack of investor confidence in the industry,” said Gerald Flattmann of Paul Hastings. Flattmann added that it could have “perhaps demoted the US from its premier...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

Latest Country Updates

Supplements

Most read articles